Cosmetics regulatory reform may not be top of mind for House Energy and Commerce Committee leadership faced with upcoming hearings on e-cigarette dangers, prescription drug pricing, gun violence, immigration policy and climate change.
Not to mention impeachment proceedings against President Donald Trump, which are bound to divert Congress’s attention from legislative matters, despite...